| P2093 | author name string | R Benamouzig | |
| | P Nicolas | |
| | M Cucherat | |
| | B Uzzan | |
| | G Des Guetz | |
| | G-Y Perret | |
| | J-F Morere | |
| | J-L Breau | |
| P2860 | cites work | Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints | Q27860640 |
| | Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer | Q27860681 |
| | Meta-analysis of Observational Studies in Epidemiology: A Proposal for Reporting | Q27861077 |
| | Systematic reviews of evaluations of prognostic variables | Q33806488 |
| | Increased microvascular blood content is an early event in colon carcinogenesis | Q34093060 |
| | Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: who benefits and by how much? | Q34546887 |
| | Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma | Q34570747 |
| | Prognostic role of angiogenesis in colorectal cancer | Q34573920 |
| | Prognostic factors in breast cancer: current and new predictors of metastasis | Q34639820 |
| | Second international consensus on the methodology and criteria of evaluation of angiogenesis quantification in solid human tumours | Q34762171 |
| | Clinical significance of angiogenesis in gastrointestinal cancers: a target for novel prognostic and therapeutic approaches | Q35165648 |
| | Microvessel density as a prognostic factor in women with breast cancer: a systematic review of the literature and meta-analysis | Q35764191 |
| | Angiogenesis of gastrointestinal tumours and their metastases--a target for intervention? | Q35792272 |
| | Predictive value of vascular endothelial growth factor (VEGF) in metastasis and prognosis of human colorectal cancer | Q36115661 |
| | Clinical significance of vascular endothelial growth factor expression and neovascularization in colorectal carcinoma | Q36179792 |
| | Vascular endothelial growth factor (VEGF) mRNA isoform expression pattern is correlated with liver metastasis and poor prognosis in colon cancer | Q36292182 |
| | Prospective study of intratumoral microvessel density, p53 expression and survival in colorectal cancer | Q36617353 |
| | An analysis of p53, BAX and vascular endothelial growth factor expression in node-positive rectal cancer. Relationships with tumour recurrence and event-free survival of patients treated with adjuvant chemoradiation | Q36644150 |
| | Role of biological markers in the clinical outcome of colon cancer | Q36646148 |
| | Both high intratumoral microvessel density determined using CD105 antibody and elevated plasma levels of CD105 in colorectal cancer patients correlate with poor prognosis | Q37340349 |
| | Expression of VEGF-C and VEGF-D at the invasive edge correlates with lymph node metastasis and prognosis of patients with colorectal carcinoma | Q38449285 |
| | Vascular endothelial growth factor-D expression is an independent prognostic marker for survival in colorectal carcinoma | Q38457306 |
| | Microvessel quantification in primary colorectal carcinoma: an immunohistochemical study | Q42076962 |
| | Vascular endothelial growth factor expression, S-phase fraction and thymidylate synthase quantitation in node-positive colon cancer: relationships with tumor recurrence and resistance to adjuvant chemotherapy | Q43573408 |
| | Clinical significance of angiogenic factor expression at the deepest invasive site of advanced colorectal carcinoma | Q44232939 |
| | Is tumour angiogenesis a prognostic factor in patients with colorectal cancer and no involved nodes? | Q44412859 |
| | Tumor angiogenesis in stage II colorectal carcinoma: association with survival | Q44428188 |
| | Microvessel quantitation and expression of VEGF in colorectal tumors | Q45008903 |
| | Impact of vascular endothelial growth factor-A expression, thrombospondin-2 expression, and microvessel density on the treatment effect of bevacizumab in metastatic colorectal cancer | Q46859430 |
| | Prognostic relevance of tumour-associated macrophages and von Willebrand factor-positive microvessels in colorectal cancer | Q47251274 |
| | Determination of molecular marker expression can predict clinical outcome in colon carcinomas. | Q47433453 |
| | Microvessel density, cyclo-oxygenase 2 expression, K-ras mutation and p53 overexpression in colonic cancer | Q48020667 |
| | The prognostic significance of tumor vascularization in patients with localized colorectal cancer. | Q52974409 |
| | Relevance of biologic markers in colorectal carcinoma: a comparative study of a broad panel | Q57006279 |
| | Tumor Angiogenesis Predicts Recurrence in Invasive Colorectal Cancer When Controlled for Dukes Staging | Q62497468 |
| | Tumor angiogenesis as a predictor of recurrence and survival in patients with node-negative colon cancer | Q70799598 |
| | Microvessel quantification and its possible relation with liver metastasis in colorectal cancer | Q71018345 |
| | Prognostic significance of the microvascular count in colorectal cancer | Q71093025 |
| | Angiogenesis as an unfavorable prognostic factor in human colorectal carcinoma | Q71170174 |
| | Tumor angiogenesis in primary and metastatic colorectal cancers | Q71591080 |
| | Tumor angiogenesis and rectal carcinoma | Q71644102 |
| | Angiogenesis in colorectal tumors: microvessel quantitation in adenomas and carcinomas with clinicopathological correlations | Q71804861 |
| | Tumor angiogenesis and mode of metastasis in patients with colorectal cancer | Q73148760 |
| | Tumor angiogenesis predicts recurrence with normal serum carcinoembryonic antigen in advanced rectal carcinoma patients | Q73163888 |
| | Microvessel densities and microvascular architecture in colorectal carcinomas and their liver metastases: significant correlation of high microvessel densities with better survival | Q73314602 |
| | Vessel counts and expression of vascular endothelial growth factor as prognostic factors in node-negative colon cancer | Q73360651 |
| | Tissue factor expression in human colorectal carcinoma: correlation with hepatic metastasis and impact on prognosis | Q73368586 |
| | EasyMA: a program for the meta-analysis of clinical trials | Q73527447 |
| | Expression of vascular endothelial growth factor and thrombospondin-1 in colorectal carcinoma | Q73552922 |
| | Vascular enumeration as a prognosticator for colorectal carcinoma | Q73603340 |
| | Prognostic role of thymidylate synthase, thymidine phosphorylase/platelet-derived endothelial cell growth factor, and proliferation markers in colorectal cancer | Q73605081 |
| | Implication of vascular endothelial growth factor and p53 status for angiogenesis in noninvasive colorectal carcinoma | Q73666498 |
| | Prognostic value of vascular endothelial growth factor expression in colorectal cancer patients | Q73670868 |
| | Clinical significance of thrombospondin-1 expression in relation to vascular endothelial growth factor and interleukin-10 expression at the deepest invasive tumor site of advanced colorectal carcinoma | Q73919435 |
| | Expression of vascular endothelial growth factor can predict event-free survival in stage II colon cancer | Q74067245 |
| | Differential assessment of vascular survival ability and tumor angiogenic activity in colorectal cancer | Q74079904 |
| | Prognostic significance of microvascular counts in rectal carcinoma | Q74345870 |
| | Association of vascular endothelial growth factor expression with tumor angiogenesis, survival and thymidine phosphorylase/platelet-derived endothelial cell growth factor expression in human colorectal cancer | Q74505899 |
| | Expression of vascular endothelial growth factor and its receptor KDR (kinase domain-containing receptor)/Flk-1 (fetal liver kinase-1) as prognostic factors in human colorectal cancer | Q77293788 |
| | Tumor angiogenesis as a prognostic predictor in colorectal carcinoma with special reference to mode of metastasis and recurrence | Q77432085 |
| | A morphometric study of neovascularization in colorectal carcinoma | Q77596973 |
| | Tumor angiogenesis in lymph node-negative rectal cancer: correlation with clinicopathological parameters and prognosis | Q77599299 |
| | Comparative efficacy of adjuvant chemotherapy in patients with Dukes' B versus Dukes' C colon cancer: results from four National Surgical Adjuvant Breast and Bowel Project adjuvant studies (C-01, C-02, C-03, and C-04) | Q77766531 |
| | Significance of angiogenic factors in liver metastatic tumors originating from colorectal cancers | Q77768074 |
| | Angiogenesis in normal tissue adjacent to colon cancer | Q77769039 |
| | Prognostic significance of angiogenesis in rectal cancer: a morphometric investigation | Q77805652 |
| | Clinical significance of vascular endothelial growth factor C expression and angiogenesis at the deepest invasive site of advanced colorectal carcinoma | Q77822776 |
| | Prognostic relevance of microvessel density in colorectal tumours | Q77896087 |
| | Vascular endothelial growth factor, CD68, and epidermal growth factor receptor expression and survival in patients with Stage II and Stage III colon carcinoma: a role for the host response in prognosis | Q78892615 |
| | Immunohistochemical microvessel count is not a reliable prognostic predictor in colorectal carcinoma | Q79193014 |
| | Endoglin (CD105) and vascular endothelial growth factor as prognostic markers in colorectal cancer | Q79347792 |
| | Vascular endothelial growth factor expression in metastatic pulmonary tumor from colorectal carcinoma: utility as a prognostic factor | Q80805609 |
| | Colorectal cancer | Q81244694 |
| | VEGF as a predictive marker of rectal tumor response to preoperative radiotherapy | Q81346792 |
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | colorectal cancer | Q188874 |
| | meta-analysis | Q815382 |
| | microvessel | Q6840468 |
| P304 | page(s) | 1823-1832 | |
| P577 | publication date | 2006-06-01 | |
| P1433 | published in | British Journal of Cancer | Q326309 |
| P1476 | title | Microvessel density and VEGF expression are prognostic factors in colorectal cancer. Meta-analysis of the literature | |
| P478 | volume | 94 | |